IMNM Stock Analysis: Buy, Sell, or Hold?
IMNM - Immunome, Inc.
$19.30
-0.31 (-1.58%)
▼
5d:
-6.99%
30d:
-11.71%
90d:
-11.1%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 11, 2026
Smart Money Accumulation
IMNM is down 5.3% this week, but smart money is accumulating calls. Top strike: $22 2026-04-17 with 281 OI. Call ratio: 88% View Scanner →
Strength: 6.4/10
Get Alerted When IMNM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IMNM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IMNM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IMNM is currently trading at $19.30, which is considered oversold relative to its 30-day fair value range of $20.54 to $22.06.
Technical Outlook: Technically, IMNM is in a uptrend. The price is currently testing key support at $19.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IMNM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $35.54 (+84.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IMNM is in a uptrend. The price is currently testing key support at $19.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IMNM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $35.54 (+84.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$20.54 -
$22.06
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding IMNM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 84.1% below Wall St target ($35.54)
- CAUTION: 5-day price weakness (-7.0%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$20.54 -
$22.06
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$19.16
Resistance Level
$21.46
Current Trend
Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.13
Wall Street Target
$35.54
(+84.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: March 31, 2026 3:03 AM ET
Data refreshes hourly during market hours. Next update: 4:03 AM
Data refreshes hourly during market hours. Next update: 4:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMNM showing a specific setup today?
Insider Activity (6 Months)
5
Buys
1
Sells
+
Net
INSIDERS SELLING
Recent Transactions
Jean Jacques Bienaime
BUY
1000 shares
2026-03-11
Clay B Siegall
BUY
4729 shares
2025-12-30
Isaac Barchas
SELL
383200 shares
2025-12-22
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 61 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 56 HOLD |
Advanced IMNM Option Strategies
Professional options setups generated by AI based on today's IMNM price and gamma walls.
